KLSE Screener
Screener
Stock Screener
Warrant Screener
Market
Entitlements
Dividend
Share issued
Financial
News
News
Announcements
Discussions
Comments
Ideas
Login
Feedback
Help
Contact us
Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
PHARMA-CF
0.005
(%)
Listing Information & Profile
Listing Information & Profile for Structured Warrants
PHARMA-CF: CW PHARMANIAGA BERHAD (MACQ)
Instrument Category
Structured Warrants
Instrument Type
CALL WARRANTS
Description
EUROPEAN-STYLE NON-COLLATERALISED CASH SETTLED CALL WARRANTS
Underlying Stock
PHARMANIAGA BERHAD
Issuer
MACQUARIE CAPITAL SECURITIES (MALAYSIA) SDN BHD
Stock Code
7081CF
Stock Short Name
PHARMA-CF
ISIN Code
MYL7081CFV57
Board
Structured Warrants
Sector
HEALTH CARE
Initial Listing Information
Listing Date
19 Nov 2020
Term Sheet Date
18 Nov 2020
Issue Date
18 Nov 2020
Issue/ Ask Price
Malaysian Ringgit (MYR) 0.3000
Issue Size Indicator
Unit
Issue Size in Unit
17,000,000
Maturity Date
31 May 2021
Name of Guarantor
Name of Trustee
Coupon/Profit/Interest/Payment Rate
Coupon/Profit/Interest/Payment Frequency
Redemption
Exercise/Conversion Period
6.33 Month(s)
Revised Exercise/Conversion Period
Not Applicable
Exercise/Strike/Conversion Price
Malaysian Ringgit (MYR) 6.5800
Revised Exercise/Strike/Conversion Price
Not Applicable
Exercise/Conversion Ratio
10:1
Revised Exercise/Conversion Ratio
Not Applicable
Settlement Type/ Convertible into
Cash
Name and contact details of market maker (If applicable)
Macquarie Capital Securities (Malaysia) Sdn. Bhd. 10th floor Menara Hap Seng No. 1 & 3 Jalan P. Ramlee 50250 Kuala Lumpur, Malaysia Telephone no.: 03-2059 8840
Circumstances under which the market maker may not be able to provide quotes (If applicable)
Please refer to Section 6.2 of the Base Prospectus dated 30 October 2020
Announcement Info
Company Name
PHARMA-CF: CW PHARMANIAGA BERHAD (MACQ)
Stock Name
PHARMA-CF
Date Announced
18 Nov 2020
Category
Listing Information and Profile
Reference Number
LIP-16112020-00005
View original announcement